182 related articles for article (PubMed ID: 38370401)
1. Chimeric antigen receptor T cells targeting the GM3(Neu5Gc) ganglioside.
Heinzelbecker J; Fauskanger M; Jonson I; Krengel U; Løset GÅ; Munthe L; Tveita A
Front Immunol; 2024; 15():1331345. PubMed ID: 38370401
[TBL] [Abstract][Full Text] [Related]
2. A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.
Casadesús AV; Fernández-Marrero Y; Clavell M; Gómez JA; Hernández T; Moreno E; López-Requena A
Glycoconj J; 2013 Oct; 30(7):687-99. PubMed ID: 23547010
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.
Dorvignit D; Boligan KF; Relova-Hernández E; Clavell M; López A; Labrada M; Simon HU; López-Requena A; Mesa C; von Gunten S
Sci Rep; 2019 Jul; 9(1):9921. PubMed ID: 31289278
[TBL] [Abstract][Full Text] [Related]
4. CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues.
Cribioli E; Giordano Attianese GMP; Coukos G; Irving M
Front Immunol; 2022; 13():951143. PubMed ID: 35990626
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside-Functionalized Nanoparticles for Chimeric Antigen Receptor T-Cell Activation at the Immunological Synapse.
Zang H; Siddiqui M; Gummuluru S; Wong WW; Reinhard BM
ACS Nano; 2022 Nov; 16(11):18408-18420. PubMed ID: 36282488
[TBL] [Abstract][Full Text] [Related]
6. GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy.
Labrada M; Dorvignit D; Hevia G; Rodríguez-Zhurbenko N; Hernández AM; Vázquez AM; Fernández LE
Semin Oncol; 2018 Jan; 45(1-2):41-51. PubMed ID: 30318083
[TBL] [Abstract][Full Text] [Related]
7. Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody.
Piperno GM; López-Requena A; Predonzani A; Dorvignit D; Labrada M; Zentilin L; Burrone OR; Cesco-Gaspere M
Gene Ther; 2015 Dec; 22(12):960-7. PubMed ID: 26181624
[TBL] [Abstract][Full Text] [Related]
8. Key role of a structural water molecule for the specificity of 14F7-An antitumor antibody targeting the NeuGc GM3 ganglioside.
Bjerregaard-Andersen K; Abraha F; Johannesen H; Oscarson S; Moreno E; Krengel U
Glycobiology; 2021 Dec; 31(11):1500-1509. PubMed ID: 34735569
[TBL] [Abstract][Full Text] [Related]
9. A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates.
Fernández-Marrero Y; Roque-Navarro L; Hernández T; Dorvignit D; Molina-Pérez M; González A; Sosa K; López-Requena A; Pérez R; de Acosta CM
Immunobiology; 2011 Dec; 216(12):1239-47. PubMed ID: 21802167
[TBL] [Abstract][Full Text] [Related]
10. Antitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside.
Dorvignit D; García-Martínez L; Rossin A; Sosa K; Viera J; Hernández T; Mateo C; Hueber AO; Mesa C; López-Requena A
Immunobiology; 2015 Dec; 220(12):1343-50. PubMed ID: 26224247
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.
Torbidoni AV; Scursoni A; Camarero S; Segatori V; Gabri M; Alonso D; Chantada G; de Dávila MT
Acta Ophthalmol; 2015 Jun; 93(4):e294-300. PubMed ID: 25403557
[TBL] [Abstract][Full Text] [Related]
12. Detection of N-glycolyl-neuraminic acid-containing glycolipids in human skin.
Manni M; Mantuano NR; Zingg A; Kappos EA; Behrens AJ; Back J; Follador R; Faridmoayer A; Läubli H
Front Immunol; 2023; 14():1291292. PubMed ID: 38094289
[TBL] [Abstract][Full Text] [Related]
13. Implication of N-glycolylneuraminic acid in regulation of cell adhesiveness of C2C12 myoblast cells during differentiation into myotube cells.
Go S; Sato C; Hane M; Go S; Kitajima K
Glycoconj J; 2022 Oct; 39(5):619-631. PubMed ID: 35639196
[TBL] [Abstract][Full Text] [Related]
14. SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the
Bousquet PA; Manna D; Sandvik JA; Arntzen MØ; Moreno E; Sandvig K; Krengel U
Front Immunol; 2022; 13():994790. PubMed ID: 36439103
[TBL] [Abstract][Full Text] [Related]
15. Structure and molecular interactions of a unique antitumor antibody specific for N-glycolyl GM3.
Krengel U; Olsson LL; Martínez C; Talavera A; Rojas G; Mier E; Angström J; Moreno E
J Biol Chem; 2004 Feb; 279(7):5597-603. PubMed ID: 14627696
[TBL] [Abstract][Full Text] [Related]
16. Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors.
Stock S; Benmebarek MR; Kluever AK; Darowski D; Jost C; Stubenrauch KG; Benz J; Freimoser-Grundschober A; Moessner E; Umana P; Subklewe M; Endres S; Klein C; Kobold S
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35902133
[TBL] [Abstract][Full Text] [Related]
17. Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody.
Fernández-Marrero Y; Hernández T; Roque-Navarro L; Talavera A; Moreno E; Griñán T; Vázquez AM; de Acosta CM; Pérez R; López-Requena A
Mol Immunol; 2011 Apr; 48(8):1059-67. PubMed ID: 21306777
[TBL] [Abstract][Full Text] [Related]
18. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
19. Engineering the binding site of an antibody against N-glycolyl GM3: from functional mapping to novel anti-ganglioside specificities.
Rojas G; Pupo A; Gómez S; Krengel U; Moreno E
ACS Chem Biol; 2013 Feb; 8(2):376-86. PubMed ID: 23138862
[TBL] [Abstract][Full Text] [Related]
20. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
